Plasma exchange for severe alveolar hemorrhage in ANCA-associated vasculitis: emulation of a target trial
American Journal of Respiratory and Critical Care Medicine · 2026
DOI: 10.1093/ajrccm/aamaf122 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift American Journal of Respiratory and Critical Care Medicine, 2026. Verfasst von Anne-Claire Sanna und 59 weiteren Autor:innen. Beteiligte Einrichtung: Service de Médecine Interne, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France. Hauptthemen laut MEDLINE: Plasma Exchange, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Hemorrhage, Pulmonary Alveoli.
Abstract (Originalsprache)
Rationale
Patients with severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)-related diffuse alveolar hemorrhage (DAH) face high mortality. In the PEXIVAS trial, plasma exchange (PLEX) did not reduce death or end-stage kidney disease, but only 9% had severe DAH.
Objectives
This study aimed to assess whether PLEX lowers mortality in patients with severe DAH.
Methods
We emulated a target trial using retrospective data from a national multicenter cohort of patients with severe AAV-related DAH. The primary endpoint was 30-day mortality after ICU admission, analyzed using a Cox model adjusted for prespecified confounders. Main Results We included 184 patients (median age 66 [53–75] years; 51% female; 51% with granulomatosis with polyangiitis; 53% MPO-ANCA positive). Of these, 144 (78.3%) received PLEX and 40 (21.7%) did not. Baseline characteristics were similar, except for more severe renal impairment (creatinine 357 vs. 171 µmol/L, P = 0.01) and more frequent cyclophosphamide use (77% vs. 55%, P = 0.01) in the PLEX group. Severity at ICU admission (median SAPS II score: 42) and mechanical ventilation needs (54%) were comparable between groups. At 30 days, overall survival was 85%. No significant difference in mortality was observed between the PLEX and no-PLEX groups: 30-day survival was 85% (95% CI 81–90) with PLEX vs. 88% (95% CI 77–96) without (HR 1.23; 95% CI 0.57–3.89). Secondary outcomes were also similar.
Conclusion
In this emulated target trial, PLEX did not reduce 30-day mortality in patients with severe AAV-related DAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service de Médecine Interne, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
- Service de Réanimation médicale, Hôpitaux Universitaires Henri Mondor, DHU ATVB, Assistance Publique-Hôpitaux de Paris, Université Paris-Est-Créteil (UPEC), Créteil, France.
- Faculté de Santé de Créteil, Université Paris Est Créteil, Institut Mondor de Recherche Biomédicale, Groupe de recherche clinique CARMAS, Créteil, France.
- Service de Médecine Intensive Réanimation, Hôpital Tenon, APHP Sorbonne Université.
- Service de Médecine Intensive Réanimation, CHU de Nice.
- Service de Médecine Intensive Réanimation, CHU de Caen Normandie, Caen, France.
ORCID-Profile: Anne-Claire Sanna, Ségolène Gendreau, Florian Reizine, Valentin Coirier, Benoit Brilland, Stanislas Faguer, Romain Paule, Etienne de Montmollin, Jean-Pierre Quenot, Hervé Lobbes, Damien Contou, Nahema Issa, Raphaël Porcher, Nicolas de Prost, Benjamin Terrier
Zitieren
APA
Sanna, A. C., Gendreau, S., Desnos, C., Lombardi, R., Malherbe, J., Titeca-Beauport, D., Reizine, F., Louis, G., Nassarmadji, K., Campagne, J., Martellosio, J. P., Deroux, A., Bendiab, E., Coirier, V., Catano, J., Pineton De Chambrun, M., Samson, M., Vigneron, C., Néel, A., …, & French Vasculitis Study Group (FVSG) and the Groupe de Recherche en Réanimation Respiratoire du patient d‘Onco-Hématologie (GrrrOH) (2026). Plasma exchange for severe alveolar hemorrhage in ANCA-associated vasculitis: emulation of a target trial. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1093/ajrccm/aamaf122
Vancouver
Sanna AC, Gendreau S, Desnos C, Lombardi R, Malherbe J, Titeca-Beauport D, et al. Plasma exchange for severe alveolar hemorrhage in ANCA-associated vasculitis: emulation of a target trial. American Journal of Respiratory and Critical Care Medicine. 2026. doi:10.1093/ajrccm/aamaf122
BibTeX
@article{Sanna2026,
author = {Sanna, Anne-Claire and Gendreau, Ségolène and Desnos, Cyrielle and Lombardi, Romain and Malherbe, Jolan and Titeca-Beauport, Dimitri and Reizine, Florian and Louis, Guillaume and Nassarmadji, Kladoum and Campagne, Julien and Martellosio, Jean-Philippe and Deroux, Alban and Bendiab, Eddine and Coirier, Valentin and Catano, Jennifer and Pineton De Chambrun, Marc and Samson, Maxime and Vigneron, Clara and Néel, Antoine and Smets, Perrine and Deltombe, Thylbert and Brilland, Benoit and Desgrouas, Maxime and Simon, Olivier and Faguer, Stanislas and Giorgiutti, Stéphane and Paule, Romain and Arrive, François and Masson, Ingrid and Quéméneur, Thomas and Durel, Cécile-Audrey and de Montmollin, Etienne and Quenot, Jean-Pierre and Perrin, François and Lobbes, Hervé and Lajoye, Quentin and Mesbah, Rafik and Outh, Roderau and Thoreau, Benjamin and Lacraz, Adeline and Philipponnet, Carole and Contou, Damien and Parazols, Fabien and Garo, Florian and Blonz, Gauthier and Ducoux, Grégoire and Yildiz, Halil and Rey, Isabelle and Di Ascia, Ludovic and Issa, Nahema and Le Guen, Pierre and Queyrel, Viviane and Eid, Rita and Arcani, Robin and Uzunhan, Yurdagul and Puéchal, Xavier and Porcher, Raphaël and de Prost, Nicolas and Terrier, Benjamin and French Vasculitis Study Group (FVSG) and the Groupe de Recherche en Réanimation Respiratoire du patient d‘Onco-Hématologie (GrrrOH), French Vasculitis Study Group (FVSG) and the Groupe de Recherche en Réanimation Respiratoire du patient d‘Onco-Hématologie (GrrrOH)},
title = {Plasma exchange for severe alveolar hemorrhage in ANCA-associated vasculitis: emulation of a target trial},
journal = {American Journal of Respiratory and Critical Care Medicine},
year = {2026},
doi = {10.1093/ajrccm/aamaf122}
}
EUVIMED